Document Detail


Intravenous nitroglycerin in acute myocardial infarction.
MedLine Citation:
PMID:  6407314     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Until recently, the use of nitroglycerin in patients with acute myocardial infarction has been contraindicated primarily because of possible hypotension or tachycardia which, with sublingual or oral preparations, would be difficult to control. The introduction of intravenous nitroglycerin and its use during experimentally induced infarction paved the way for its use in patients with acute myocardial ischemia. It was shown that nitroglycerin, administered intravenously during experimentally induced coronary artery occlusion, redistributed flow to the subendocardium of the ischemic area while it maintained flow to the normal areas and was associated with decreased S-T segment elevation. Preliminary studies in patients with acute infarction have confirmed the beneficial effect of intravenous nitroglycerin on S-T segment elevation, and a subsequent study in 31 patients with acute infarction showed a decrease in infarct size with improved hemodynamics. In a more recent randomized prospective study in 85 patients with acute myocardial infarction, we found that intravenous nitroglycerin was associated with a decrease in infarct size in patients with inferior infarction (36 percent reduction, p less than 0.05) but that it had no effect on infarct size in patients with anterior infarction. Whether or not nitroglycerin should be used routinely for reduction of infarct size remains to be determined, but results indicate that it is effective and safe for the treatment of cardiac failure in patients with acute myocardial infarction.
Authors:
R Roberts
Related Documents :
21376834 - Differentiating pacemaker-mediated tachycardia from tachycardia due to atrial tracking:...
2488114 - Imaging of acute myocardial infarction by magnetic resonance tomography (mrt) using the...
3886934 - Acute focal bacterial nephritis: a systematic approach to diagnosis and treatment.
2600454 - Mesenteric venous infarction in acute pancreatitis.
25229174 - Reversible cerebral vasoconstriction syndrome possibly induced by etoricoxib.
15721494 - Normal angiogram in acute coronary syndrome-preangiographic risk stratification, angiog...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The American journal of medicine     Volume:  74     ISSN:  0002-9343     ISO Abbreviation:  Am. J. Med.     Publication Date:  1983 Jun 
Date Detail:
Created Date:  1983-07-29     Completed Date:  1983-07-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0267200     Medline TA:  Am J Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  45-52     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Pressure / drug effects
Coronary Circulation / drug effects
Female
Heart Rate / drug effects
Humans
Infusions, Parenteral
Male
Middle Aged
Myocardial Infarction / drug therapy*,  pathology
Nitroglycerin / administration & dosage*,  pharmacology
Prospective Studies
Random Allocation
Chemical
Reg. No./Substance:
55-63-0/Nitroglycerin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of glyceryl trinitrate on coronary and systemic hemodynamics in man.
Next Document:  Comparison of intravenous nitroglycerin and sodium nitroprusside in acute myocardial infarction.